发明名称 VACCINE COMPOSITION
摘要 <p>A multi-valent vaccine composition is described comprising a conjugate of the capsular polysaccharide of H. influenzae b not adsorbed onto an aluminium adjuvant salt, and two or more further bacterial polysaccharides. A multi-valent vaccine composition is also described comprising a whole-cell pertussis component, tetanus toxoid, diphtheria toxoid, Hepatitis B surface antigen, a conjugate of the capsular polysaccharide of H. influenzae b, and a conjugate of a capsular polysaccharide of N. meningitidis type A or C (or both). Furthermore, a multi-valent vaccine composition is described comprising a whole-cell pertussis component, tetanus toxoid, diphtheria toxoid, and a low dose of a conjugate of the capsular polysaccharide of H. influenzae b.</p>
申请公布号 CA2783274(A1) 申请公布日期 2002.01.03
申请号 CA20012783274 申请日期 2001.06.27
申请人 GLAXOSMITHKLINE BIOLOGICALS S.A. 发明人 BOUTRIAU, DOMINIQUE;CAPIAU, CARINE;DESMONS, PIERRE MICHEL;LEMOINE, DOMINIQUE;POOLMAN, JAN
分类号 A61K39/295;A61K39/02;A61K39/05;A61K39/08;A61K39/09;A61K39/095;A61K39/10;A61K39/102;A61K39/106;A61K39/112;A61K39/116;A61K39/13;A61K39/29;A61K39/39;A61P31/04;A61P31/12;A61P31/16;A61P37/04 主分类号 A61K39/295
代理机构 代理人
主权项
地址